市場調査レポート

商品コード

1458079

スマート吸入器の世界市場規模、シェア、成長分析、タイプ別、流通チャネル別、最終用途別-産業別予測

Global Smart Inhalers Market Size, Share, Growth Analysis, By Type(Dry powdered inhalers and metered dose inhalers ), By Distribution Channel, By End-Use - Industry Forecast 2024-2031

出版日: 2024年03月27日 | 発行: SkyQuest

| ページ情報: 英文 219 Pages | 納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 808,462円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 945,748円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,083,034円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=152.54円

全表示
概要
目次

概要

サンプル依頼リストに入れる

スマート吸入器の世界市場規模は2022年に122億2,000万米ドルと評価され、2023年の146億4,000万米ドルから2031年には621億1,000万米ドルに成長し、予測期間中（2024～2031年）のCAGRは19.8％で成長する展望です。

喘息やCOPDを含む呼吸器疾患の治療は、医療セグメントの一セグメントであるスマート吸入器の世界市場が急速に拡大することによって革命を起こしつつあります。スマート吸入器は、センサーとBluetooth技術を使って患者の吸入器使用を追跡・監視する医療機器です。医療の専門家は、スマート吸入器が収集するデータを利用して、処方スケジュールに対する患者のアドヒアランスをよりよく監視し、必要に応じて治療戦略を修正することができます。医療従事者が患者の薬剤使用をモニターし、治療計画をリアルタイムで調整できるようにすることで、業界は呼吸器疾患治療の有効性と効率性の向上を目指しています。

技術分析
価格分析
サプライチェーン分析
バリューチェーン分析
市場のエコシステム
IP分析
貿易分析
スタートアップ分析
原材料の分析
イノベーションマトリクス
パイプライン製品の分析
マクロ経済指標
主要投資の分析
主要成功要因
競合の程度

市場力学と展望

市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
規制情勢
ポーターの分析
将来の混乱についての特別な考察

スマート吸入器の世界市場：タイプ別

市場概要
乾燥粉末吸入器（DPI）と定量吸入器（MDI）

スマート吸入器の世界市場：流通チャネル別

市場概要
病院薬局
小売薬局
オンライン薬局

スマート吸入器の世界市場：最終用途別

市場概要
病院
在宅医療
その他

スマート吸入器の世界市場規模：地域別

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他の欧州地域
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
ラテンアメリカ
- ブラジル
- その他のラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2021年）
主要市場企業が採用した戦略
主要成功戦略
市場における最近の活動
主要企業の市場シェア（2021年）

主要企業プロファイル

Teva Pharmaceuticals（イスラエル）
GlaxoSmithKline（英国）
Novartis（スイス）
AstraZeneca（英国）
Boehringer Ingelheim（ドイツ）
Philips Respironics（米国）
Propeller Health（米国）
Vectura Group（英国）
Opko Health（米国）
Adherium Limited（ニュージーランド）
AptarGroup（米国）
Cohero Health（米国）
H&T Presspart（英国）
3M Company（米国）
Cipla（インド）
Mundipharma（英国）
Glenmark Pharmaceuticals（インド）
Chiesi Farmaceutici（イタリア）
Propeller Health（米国）
Sensirion AG（スイス）

Product Code: SQMIG35A2315

Global Smart Inhalers Market size was valued at USD 12.22 billion in 2022 and is poised to grow from USD 14.64 billion in 2023 to USD 62.11 billion by 2031, growing at a CAGR of 19.8% during the forecast period (2024-2031).

The treatment of respiratory conditions including asthma and COPD is being revolutionized by the quickly expanding global smart inhalers market, a sector of the healthcare sector. Smart inhalers are medical devices that track and monitor patients' inhaler usage using sensors and Bluetooth technology. Healthcare professionals can use the data that smart inhalers collect to better monitor patient adherence to prescription schedules and modify treatment strategies as necessary. By allowing healthcare practitioners to monitor patient drug usage and make real-time treatment plan adjustments, the industry aims to improve the efficacy and efficiency of respiratory disease therapy.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Smart Inhalers Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Smart Inhalers Market Segmental Analysis

Global Smart Inhalers Market is segmented on the basis of type, distribution channel, end-use, and region. By type, the market is segmented into dry powdered inhalers (DPIs) and metered dose inhalers (MDIs). By distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. By end-use, the market is segmented into hospitals, homecare settings, and others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Smart Inhalers Market

Innovations in technology are a major factor propelling the market for smart inhalers. The treatment of respiratory disorders has changed dramatically as a result of the introduction of sophisticated sensors, networking choices, and data analytics tools. Personalized treatment and better patient outcomes are made possible by smart inhalers' ability to gather and communicate data in real-time to healthcare practitioners about medicine usage, inhaler technique, and environmental variables. One digital therapeutics startup, Propeller Health, has created a sensor-based smart inhaler platform. The platform is made up of a sensor that fits onto common inhalers and monitors drug intake. The gathered information is transferred to a smartphone app, which gives patients and medical professionals information and alerts.

Restraints in the Global Smart Inhalers Market

The comparatively expensive price of smart inhalers in comparison to traditional inhalers is one of the market's limitations. Smart inhalers are more expensive because of their sophisticated technology and connection features. Their broad adoption may be constrained by their cost, especially in areas with scarce healthcare resources and affordability issues. For instance, the cost of a smart inhaler might vary from $100 to $300, based on the features and brand. Patients with low incomes or no insurance may find this increased expense to be problematic. Because of this, the market growth of smart inhalers may be hampered in some markets where their adoption is delayed.

Market Trends of the Global Smart Inhalers Market

The incorporation of machine learning (ML) and artificial intelligence (AI) algorithms into inhaler technology is a significant trend in the smart inhalers market. Large datasets gathered from smart inhalers can be analyzed by AI and ML approaches, which can also spot trends and offer predictive insights. This makes it possible for medical professionals to anticipate exacerbations, optimize medicine dosage, and customize treatment regimens. For instance, the digital health startup Cohero Health has created a smart inhaler system that uses ML and AI algorithms. In order to give patients and healthcare professionals individualized recommendations and real-time feedback, the system examines inhaler usage trends, environmental data, and patient-specific information. This trend demonstrates how AI and ML can be used to improve patient outcomes and the management of respiratory diseases.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Smart Inhalers Market by Type

Market Overview
Dry powdered inhalers (DPIs) and metered dose inhalers (MDIs)

Global Smart Inhalers Market by Distribution Channel

Market Overview
Hospital pharmacies
retail pharmacies
and online pharmacies

Global Smart Inhalers Market by End-Use

Market Overview
Hospitals
homecare settings
and others

Global Smart Inhalers Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Teva Pharmaceuticals (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boehringer Ingelheim (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Philips Respironics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Propeller Health (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vectura Group (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Opko Health (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Adherium Limited (New Zealand)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AptarGroup (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cohero Health (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
H&T Presspart (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
3M Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cipla (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mundipharma (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Glenmark Pharmaceuticals (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Chiesi Farmaceutici (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Propeller Health (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sensirion AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments